TAKASHI UEDA, SHINYA UGAWA, YUSUKE ISHIDA, AKI HONDOH, and SHOICHI SHIMADA G-protein-coupled receptors (GPcrs) are important therapeutic targets for many areas of drug research and development. Although chimeric Gα 16 proteins are valuable tools for detecting the activation of Gα i/o -coupled receptors, the details of the activation process remain unclear. the authors introduce a series of chimeras that combine both Gα 16 and Gα i/o (Gα 16/o , Gα 16/i2 , and Gα 16/i3 ) into a well-established transient expression system to examine the ability of these chimeras to interact with d 2 long-form (d 2l ) dopamine and 5-Ht 1A serotonin receptors. the pec 50 data obtained for known agonists were similar to results from previous studies that used other cell-based assays, thus indicating sufficient sensitivity for the assay. Moreover, quinpirole exhibited similar intrinsic activity to dopamine at the d 2l receptor, whereas S-(-)-3-PPP displayed partial activity of dopamine and quinpirole in the presence of the Gα 16/o chimera. the potency of dopamine for d 2l receptors was similar among Gα 16/o , Gα 16/i2 , and Gα 16/i3 . in contrast, the 5-Ht 1A receptor exhibited a significantly preferential coupling for Gα 16/i3 compared with Gα 16/i2 when serotonin was used as a ligand. this finding was in close agreement with the results of previous reports. the present system could therefore be used as a rapid functional assay for high-throughput screening and deorphanization. (Journal of Biomolecular Screening 2009:781-788) 
INTRODUCTION

G
-Protein-couPled recePtors (GPcrs) are the largest family of membrane-bound receptors and are also the targets of many drugs. they convey extracellular signals to the cell interior by activating intracellular processes such as the heterotrimeric G-protein-dependent signaling pathways. depending on their coupling specificity, most GPcrs are often referred to as Gα q , Gα i/o , or Gα s , designations that reflect their primary signal transduction pathways. Gα 16 possesses the rare ability to recognize a wide range of GPcrs and can also facilitate the characterization of orphan GPcrs. 1 in addition, a variety of chimeric Gα 16 proteins with 44-amino acid-long Gα i/o -specific sequences at their c termini (named Gα 16/z , Gα 16/o , Gα 16/i2 , and Gα 16/gust ) have been reported to improve the recognition of Gα 16 by Gα i/o -linked GPcrs. [2] [3] [4] However, it is unknown whether these Gα 16 chimeras could be used to elucidate such details of GPcr pharmacology as ligand deorphanization.
evidence exists that some receptors interact with more than one G-protein and thus influence different signaling pathways. 5 the d 2 dopamine receptor, one of the most studied monoaminergic Gα i/o -coupled GPcrs, has been shown to interact with various G-proteins that differentially influence signaling events. in one study, interaction with Gα o was shown to indirectly inhibit calcium channels, whereas interaction with Gα i subtypes has been shown to indirectly inhibit adenylyl cyclase. 6 Moreover, the 5-Ht 1A serotonin receptor interacts preferentially with the Gα i /Gα o /Gα z subtypes of G-protein. the nature of G-protein subtypes also influences agonist specificity. 7 current assays for the Gα i/olinked GPcr-G-protein interaction use insect cells 5, 8 or human embryonic kidney 293 (HeK293) cells that stably express GPcrs. 9 these assays measure radioactivity using competition guanosine-5′-O-(3′-[
35 s]thio)-triphosphate ([ 35 s] GtPγs) binding assays. 8, 9 investigations into G-protein subtype-related ligand specificity for GPcrs could be facilitated by a rapid functional assay of naive GPcrs, which is amenable to high-throughput screening (Hts). the main objective in the present study is to develop an assay system that forces Gα i/o -coupled receptors to signal through calcium mobilization by using modified Gα 16 proteins. this creates the advantage of using a single assay platform that is based on calcium detection in Hts and orphan receptor ligand fishing.
MATERIALS AND METHODS
Construction of Gα proteins and chimeras
Human full-length Gα 16 was obtained from Hl60 cell, which is a human leukemic cell line. Gα 15 , the mouse ortholog of Gα 16 , was obtained from mouse blood tissues by reverse transcriptionpolymerase chain reaction (rt-Pcr) using the following primers: for Gα 16 (GenBank Accession no. nM_002068), sense 5′-cGAtGccAcccGGtGccGActGA -3′ (224-246) and antisense 5′-cctGGGtcAcAGcAGGttGAtct-3′ (1367-1389); for Gα 15 (GenBank Accession no. nM_010304), sense 5′-tGtcAcctGGtGGtctGtGA-3′ (242-261) and antisense 5′-tcAcAGcAGGttGAtctcGt-3′ (1377-1396). Mouse full-length Gα o , Gα i1 , Gα i2 and Gα i3 complementary dnAs (cdnAs) were amplified in mouse brain tissues containing striatum and prefrontal cortex using the following primers: for Gα o (GenBank Accession no. nM_010308), sense 5′-ttGAGcccAGGctctGctct-3′ (401-420) and antisense 5′-AGAGGtcAGtAcAAGccGcA-3′ (1367-1389); for Gα i1 (GenBank Accession no. nM_010305), sense 5′-cGGAc tAGcAGAcctcGcctccAGctt-3′ (121-147) and antisense 5′-GcAGAActtAGAAGAGAccAcA-3′ (1295-1316); for Gα i2 (GenBank Accession no. nM_008138), sense 5′-GAActGcGGAcctGAGAGct-3′ (9-28) and antisense 5′-tcAGAAGAGGccAcAGtccttcA-3′
(1171-1193); and for Gα i3 (GenBank Accession no. nM_010306), sense 5′-AcccGtctccGccGGtGtGt-3′ (31-50) and antisense 5′-cctctcAAtAAAGcccAcAttcct-3′
(1155-1178). Although full-length Gα i1 messenger rnA (mrnA) was not detected in brain samples, the other Gα proteins (Gα o , Gα i2 , and Gα i3 ) were clearly amplified (Fig. 1A) . All of the chimeras were constructed by Pcr using human Gα 16 and mouse-appropriated Gα complementary dnAs (cdnAs) as templates. We constructed Gα 16 -based chimeras by replacing 44 amino acid sequences at the c terminus of Gα 16 with those of Gα o , Gα i2 , and Gα i3 (named Gα 16/o , Gα 16/i2 , and Gα 16/i3 ; Fig. 1B ). All fulllength Gα-subunit cdnAs were subcloned into a pcdnA3.1(+) mammalian expression vector (invitrogen, carlsbad, cA).
Construction of dopamine and serotonin receptors
Mouse full-length d 2 dopamine receptor long-form (d 2l ) and 5-Ht 1A and 5-Ht 2A serotonin receptors were amplified from mouse brain cdnAs using the following specific primers: for d 2l (GenBank Accession no. nM_010077), sense 5′-ActGccccAAtGGAtccAct-3′ (86-105) and antisense 5′-tcAGcAGtGcAGGAtcttcA-3′ (1410-1429); for 5-Ht 1A (GenBank Accession no. nM_008308), sense 5′-GcAGGcAtGGAtAtGttcAGtct-3′ (486-508) and antisense 5′-tcAGcGGcAGAActtGcActtGA-3′ (1735-1757); and for 5-Ht 2A (GenBank Accession no. nM_172812), sense 5′-cAtctGctAcAActtccGGcttA-3′ (1068-1090) and antisense 5′-tcAcAcAcAGctAAccttttcAttcA-3′ (2484-2509). We subcloned each open reading frame with 5′ noncoding sequences into the pcdnA3.1(+) vector.
Transfection of HEK293T cells
Human embryonic kidney 293t (HeK293t) cells were cultured with dulbecco's modified eagle's medium (dMeM) supplemented with 10% fetal calf serum (Fcs) (v/v) at 37 °c in humidified air with 5% co 2 . For transfection, cells were seeded onto 100-mm dishes or uncoated glass coverslips in 35-mm chambers. After 24 h at 37 °c, the cells were washed in dMeM and transfected with both the Gα subunit and the receptor using lipofectAmine 2000 reagent (invitrogen) according to the manufacturer's instructions. transfection efficiencies were estimated by cotransfecting with a green fluorescent protein (GFP) reporter plasmid or by immunohistochemistry, and the efficiency typically reached >70%.
Calcium imaging
transfected cells on glass coverslips were moved 24 h later to an assay chamber and were loaded with 5 µM Fura-2/AM (invitrogen) for 30 min at room temperature. cells were washed in 500 µl of assay buffer (10 mM HePes, 130 mM nacl, 10 mM glucose, 5 mM Kcl, 2 mM cacl 2 , and 1.2 mM Mgcl 2 [pH 7.4]) and stimulated with test compounds for 15 s using a bath perfusion system at a flow rate of 5 ml/min ( Fig. 2A) . We randomly selected Fura-2-loaded cells (100 cells/assay), and the effects of test compounds on internal calcium mobilization were measured with the commercially available ArGus/Hisca system (Hamamatsu Photonics, shizuoka, Japan). the system was set for bottom-read with 2 alternative excitation wavelengths (340 nm and 380 nm) and a 510-nm emission wavelength. to ensure that the cells were not desensitized as a result of previous ligand application, a 180-to 300-s interval was maintained between each application of test compounds. ratios (340 nm/380 nm) were obtained by calculating the fluorescence intensities of 510 nm at 340-and 380-nm excitation wavelengths with the ArGus/Hisca Version 1.65 software. For further analysis, we selected cells showing concentration-dependent internal calcium mobilization after the compound was applied (10-15 cells/assay).
Data analysis
A 3-parameter logistic equation was used to fit the data and to calculate both pec 50 and relative e max values (Prism Version 4.0; GraphPad, la Jolla, cA). data are reported as the mean ± seM from at least 3 to 5 separate experiments. statistical comparisons were performed using analysis of variance (AnoVA), followed by tukey's post hoc test where appropriate. A value of p < 0.05 was considered statistically significant.
RESULTS
Construction of Gα 16 chimeras with Gα i/o protein sequences
to analyze the coupling of d 2l dopamine and 5-Ht 1A serotonin receptors with different Gα proteins, we first performed rt-Pcr analyses using cdnAs from mouse striatum and prefrontal cortex, which are brain tissues that express these receptors. We thus obtained 3 types of Gα i/o subunits-Gα o , Gα i2 , and Gα i3 -although we could not amplify Gα i1 (Fig. 1A) . numerous studies on Gα i subunits have attested to the importance of the c terminal tail of the α subunit as one of the major receptor contact regions. [10] [11] [12] indeed, incorporation of α4/β6, α5, and extreme c terminal (ect) regions of Gα z into a Gα 16 backbone (Gα 16/z ) improved the recognition of Gα i/o -coupled receptors. 2 We therefore constructed 3 Gα 16 /Gα i/o chimeras (Gα o , Gα i2 , and Gα i3 ) by replacing the c terminal 44 amino acids of Gα o , Gα i2 , and Gα i3 with those of Gα 16 (Fig. 1B) .
Interaction of D 2L dopamine receptor with Gα 16 /Gα i/o chimeras
We used a well-established transient expression system to measure intracellular calcium mobilization and to examine the ability of the Gα 16 /Gα i/o chimeras to interact with the d 2l receptors ( Fig. 2A) . Because the dopamine receptor modestly coupled to Gα 16 , 2 we also analyzed the receptor coupling in our system. As shown in Figures 2B and 3 (Fig. 2B) . However, presence of the endogenous receptor (M3) in HeK293t cells did not complicate measurements of signaling via the d 2l receptor.
to investigate whether the coupling of the d 2l receptor with Gα 16 /Gα i/o chimeras had any effect on receptor pharmacology, we determined the pec 50 and e max values for a set of known d 2l biogenic amine agonists of various potencies (Fig. 3B-D) . the efficacy and potency of quinpirole on d 2l receptors were similar to those of dopamine on all Gα 16 /Gα i/o chimeras. in contrast, S-3-(3-hydroxyphenyl)-n-propylpiperidine (S-(-)-3-PPP) exhi bited a lower e max than dopamine and quinpirole in the presence of Gα 16 (Fig. 4A) . notably, there were differences among Gα 16/o , Gα 16/i2 , and Gα 16/i3 in the ability to interact with 5-Ht 1A receptors. the Gα 16/i3 chimera had a higher affinity for the 5-Ht 1A receptor than Gα 16/i2 (1-way AVoVA, p < 0.01). in contrast, Gα 16 and Gα 15 modestly coupled to the 5-Ht 1A receptor in response to 5-Ht stimulation, and the ec 50 value was higher by more than 100-fold when compared with Gα 16/i3 (Fig. 4A). 
FIG. 3. (A) dose-dependent dopamine-induced stimulation of calcium mobilization by the d 2l dopamine receptor via Gα 16/o (■), Gα 16/i2 (▲), Gα 16/i3 (▼), Gα 15 (♦), and Gα 16 (•). (B-D) dose-dependent agonist stimulation of calcium mobilization by the d 2l receptor via (B) Gα 16/o , (C) Gα 16/i2 , and (D) Gα 16/i3 in the presence of varying concentrations of different ligands: dopamine (■), quinpirole (▼), and S-(-)-3-PPP (▲). data
shown are means ± seM; full details are provided in Table 1 .
We also performed an inhibition study for antagonists using the present system. spiperone acts as an antagonist on 5-Ht 1A receptors. We transiently transfected 5-Ht 1A and Gα 16/o into HeK293t cells and then assayed for internal calcium release induced by 10 nM 5-Ht in the presence of various concentrations of spiperone (100 pM to 100 µM). spiperone inhibited the increase in intracellular calcium as a result of 5-Ht-mediated activation of the 5-Ht 1A receptor in a dose-dependent manner (Fig. 4B) . the ic 50 value was 560 ± 250 nM (mean ± seM).
Influence of Gα 16 /Gα i/o chimeras on the endogenous Gα q -linked receptor signaling cascade
to apply this methodology to orphan receptors, we needed to examine whether competition exists between the endogenous Gα q and recombinant chimeric Gα proteins in a universal assay platform designed to integrate the receptor signals. serotonin 5-Ht 2A receptors interact with the Gα q subunit to transduce receptor activation.
14 Many studies have shown that the activation of 5-Ht 2A receptors by agonists causes an increase in intracellular calcium via the endogenous Gα q proteins in HeK293 cells. We thus examined the influence of the present Gα 16 /Gα i/o chimeras on the endogenous Gα q subunit signaling cascade, which is mediated through the GPcr. We transiently transfected 5-Ht 2A receptors with or without Gα 16/o into HeK293t cells and then measured the changes in intracellular calcium after ligand stimulation. in cells expressing 5-Ht 2A receptors without any Gα protein, stimulation by 5-Ht significantly increased intracellular calcium in a dose-dependent manner (Fig. 5) 
DISCUSSION
cell-based assay technologies allow the examination of receptors in an environment that is physically similar to that in tissues. intact cells, rather than membranes, can provide functional amplified readouts that are simple to automate and quantify. indeed, most cell-based assays have now been widely developed and used to such a degree that they have been adopted into the Hts programs of almost all institutions involved in drug discovery and development. However, the applicability of these assays depends on the nature of the association of G-protein with the GPcr. Measurement of the cAMP levels is most appropriate for GPcrs that are coupled to Gα s and Gα i , whereas assays that measure either iP3 or calcium are optimal for GPcrs coupled to Gα q . 15, 16 in the present study, we have developed a single cellbased assay system that measured intracellular calcium mobilization to analyze Gα i/o -coupled receptors using 3 Gα 16 chimeras containing a sequence of 44 Gα i/o -specific amino acids at the c terminus (Gα 16/o , Gα 16/i2 , and Gα 16/i3 ). this approach could standardize readouts and allowed the use of transiently transfected cell populations to evaluate the pharmacology of the receptor.
We first analyzed the interaction of d2 dopamine receptors with Gα i/o proteins by coexpressing d 2l with each of the Gα 16 / Gα i/o chimeras in HeK293t cells. All d 2 agonists examined caused increases in intracellular calcium with all of the Gα 16 / Gα i/o chimeras in d 2l receptor-expressing cells. Quinpirole was found to exhibit intrinsic activity similar to that of endogenous dopamine on all Gα 16 /Gα i/o chimeras, whereas S-(-)-3-PPP displayed partial activity when compared with dopamine and quinpirole on Gα 16/o and Gα 16/i2 . the ec 50 values of dopamine were 3.2 nM (Gα 16/i3 ) to 10.4 nM (Gα 16/i2 ), which were comparable to previous analyses using the cAMP assays (ec 50 = 2.4 nM) 17 and MAPK activation assays (ec 50 = 8.8 ± 0.9 nM) 18 on chinese hamster ovary (cHo) cells that expressed the d 2l receptors ( Table 1) . We also analyzed the 5-Ht 1A receptor, another Gα i/o -coupled receptor. serotonin (5-Ht) increased intracellular calcium in HeK293t cells that expressed the recombinant 5-Ht 1A and Gα 16 /Gα i/o chimeras in a dose-dependent manner (Fig. 4) . the ec 50 values were 2.6 nM (Gα 16/i3 ) to 46.5 nM (Gα 16/i2 ; Table 1 ). these results were also similar to those in previous analyses of Xenopus oocytes (ec 50 = 4.2 nM) and cHo-K1 cells (ec 50 = 10.2 nM 19 ; Table 1 ). thus, both Gα i/ocoupled receptors appeared to retain normal pharmacological behavior when coupled to Gα 16 /Gα i/o chimeras, indicating that our system successfully converted the activation of Gα i/o -coupled receptors to intracellular calcium mobilization.
there is accumulating evidence for agonist specificity among G-protein subtypes. 5, 8, 9 Because recent studies have mostly used elaborate [
35 s]GtPγs binding assays, we addressed the question using a generic calcium imaging assay in this study. With regard to the d 2l receptor, previous studies have shown that the majority of dopamine d 2 receptor agonists increased (Table 1) . 8, 9 in the present study, however, there were no statistically significant differences among the pec 50 values obtained for Gα o , Gα i2 to allow us to convincingly rank the potency differences. in addition, the present assay showed different properties of S-(-)-3-PPP in Gα i2 and Gα i3 preparations compared with previous [
35 s] GtPγs-binding assays. Gazi et al. 8 have reported that S-(-)-3-PPP was a partial agonist in the Gα o and Gα i3 preparations but not in the Gα i2 preparation, whereas lane et al. 9 recently demonstrated partial agonist function in Gα o1 and antagonist/ inverse agonist function in Gα i2 and Gα i3 . this discrepancy may be due to differences in assay technology. the present assay detected more amplified signals at the endpoint of the intracellular Plc-iP3 pathway, which was different from the [ 35 s]GtPγs binding assay that measures the functional consequence of receptor occupancy at one of the earliest receptormediated events. the chimeric Gα 16 protein approach may be of limited value in detecting subtle differences between signaling through the different G-proteins. nevertheless, the calcium flux assay that we described here should be useful for the rapid screening of a library of compounds because our system showed that S-(-)-3-PPP acted as a partial agonist for d 2l receptors in the presence of the Gα 16/o chimera, a finding that was similar to that obtained from previous [ 14 Previous studies have demonstrated that agonist application promoted the physical coupling of the 5-Ht 1A receptor to G-proteins in human epithelial carcinoma cell lines (Hela cells and cHo cells). the authors in these studies used high-affinity agonist binding and co-immunoprecipitation assays. Agonist treatment induced coupling of the 5-Ht 1A receptors to G-proteins with an apparent rank order of Gα i3 > Gα i2 > Gα z . 20, 21 in our present study, we demonstrated that the 5-Ht 1A receptor exhibited preferential coupling for Gα i3 when 5-Ht was used as a ligand. despite using markedly different transfection methods and assay systems, our results were in line with previous reports that found the 5-Ht 1A receptor to functionally couple almost exclusively through the α-subunits of Gα i/o/z proteins, with a likely rank order of Gα i3 > Gα i2 . 14 Because it has been reported that regional differences exist in the coupling of 5-Ht 1A receptors to G-proteins in the rat brain, 22 it may be possible that differential coupling of 5-Ht 1A receptors to G-proteins may explain the in vivo actions of drugs that act on the GPcr.
A number of orphan GPcrs still exist in the human genome. identifying natural ligands for the receptors will help expand our understanding of the physiology and pharmacology of the receptors. 23 in the present study, we forced Gα i/o -coupled receptors to signal through calcium mobilization. Because the present Gα 16 /Gα i/o chimeras may have interfered with the signals from Gα q -coupled receptors in HeK293t cells, we examined whether the chimeric proteins influenced functional expression of recombinant 5-Ht 2A receptors, which are known to couple to endogenous Gα q and induce calcium mobilization. As shown in Figure 5 , the chimera did not show any significant effect on 5-Ht 2A receptors. therefore, the present chimeras could also be applied in the deorphanization of GPcrs in combination with endogenous Gα q proteins.
in conclusion, we have developed a single cell-based heterologous expression assay for d 2l and 5-Ht 1A receptors with various types of Gα proteins. the responses to known ligands and the sensitivity of this assay were comparable with those observed for other cell-based assays. therefore, the present Gα 16 /Gα i/o chimeras could be a useful tool to analyze orphan Gα i -linked GPcrs and to characterize receptor targeting by drugs.
